{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products dHDL Slide",
        "HDL Cholesterol assay"
    ],
    "Submitter Information": "Ortho Clinical Diagnostics",
    "510(k) Number": "K120609",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042006"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS"
    ],
    "Summary Letter Date": "November 26, 2012",
    "Summary Letter Received Date": "August 10, 2012",
    "Submission Date": "August 9, 2012",
    "Regulation Number(s)": [
        "21CFR862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "HDL Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS 250 Chemistry System",
        "VITROS 350 Chemistry System",
        "VITROS 950 Chemistry System",
        "VITROS 5,1 FS Chemistry System",
        "VITROS 4600 Chemistry System",
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Non-HDL precipitation",
        "Enzymatic detection",
        "Reflectance spectrophotometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Slide",
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Chemistry Products dHDL Slide, a modified dry multilayered slide for quantitative HDL cholesterol assay in serum and plasma",
    "Indications for Use Summary": "For in vitro diagnostic use to quantitatively measure HDL cholesterol (HDLC) concentration in serum and plasma using VITROS Chemistry Systems to evaluate coronary heart disease risk",
    "fda_folder": "Clinical Chemistry"
}